Karli Rosner

Summary

Affiliation: Wayne State University
Country: USA

Publications

  1. pmc WT1 marker is not sufficient for distinguishing between melanoma and melanocytic nevi
    Karli Rosner
    Laboratory for Molecular Dermatology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA
    J Cutan Pathol 36:1077-82. 2009
  2. doi request reprint Engineering a waste management enzyme to overcome cancer resistance to apoptosis: adding DNase1 to the anti-cancer toolbox
    K Rosner
    Laboratory for Molecular Dermatology, Program in Molecular Biology and Genetics, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA
    Cancer Gene Ther 18:346-57. 2011

Collaborators

Detail Information

Publications2

  1. pmc WT1 marker is not sufficient for distinguishing between melanoma and melanocytic nevi
    Karli Rosner
    Laboratory for Molecular Dermatology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA
    J Cutan Pathol 36:1077-82. 2009
    ..For this reason, pathologists have sought after immunohistochemistry to assist with difficult cases. Recently, Wilms' tumor 1 protein (WT1) has been suggested to differentiate between melanoma and melanocytic nevi...
  2. doi request reprint Engineering a waste management enzyme to overcome cancer resistance to apoptosis: adding DNase1 to the anti-cancer toolbox
    K Rosner
    Laboratory for Molecular Dermatology, Program in Molecular Biology and Genetics, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA
    Cancer Gene Ther 18:346-57. 2011
    ..Coupled to different tissue-specific gene expression elements, this recombinant DNase1 may serve as a platform for eliminating a variety of cancer types...